The pharmaceutical sector is witnessing a significant shift in glucose treatment with the arrival of GLP-1 patches. These innovative vehicles offer a possibly easy option to subcutaneous injections for individuals dealing with diabetes. By bypassing the necessity for frequent pokes, GLP-1 skin devices promise to improve user compliance and complete